Literature DB >> 2509562

IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma.

M Lehn1, W Y Weiser, S Engelhorn, S Gillis, H G Remold.   

Abstract

The effect of IL-4 on the IFN-gamma-induced state of activation of cultured human monocytes was investigated with regard to their ability to produce hydrogen peroxide and their antileishmanial capacity towards the intracellular parasite Leishmania donovani. IL-4 was found to inhibit the IFN-gamma-dependent hydrogen peroxide production of monocytes. Treatment of monocytes with IFN-gamma (200 to 600 U/ml) for 48 h increased the hydrogen peroxide production fourfold above background. Coincubation of the monocytes with IL-4 (1 to 1000 U/ml) and IFN-gamma (200 to 600 U/ml) inhibited this increase by 50 to 100%. IL-4 alone did not modulate the hydrogen peroxide production of monocytes. Pretreatment of monocytes with IL-4 for 20 min to 3 h was already effective in preventing the IFN-gamma response. Addition of IL-4 not later than 6 h after the start of incubation with IFN-gamma was necessary for an optimal inhibitory effect. IL-4 also inhibited the IFN-gamma-induced antileishmanial capacity of monocytes: IFN-gamma (1000 U/ml) induced a 54 +/- 10% reduction in the number of parasites. Monocytes treated with combinations of IL-4 (100 to 1000 U/ml) and IFN-gamma (1000 U/ml) were unable to reduce the parasite numbers. IL-4 alone did not alter the uptake of Leishmania donovani nor induce antileishmanial activity. These results demonstrate that IL-4 disables human cultured monocytes to respond to IFN-gamma activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509562

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Aspirin triggered lipid mediators: novel inhibitors of leucocyte trafficking.

Authors:  C N Serhan; C B Clish
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route.

Authors:  C A Power; G Wei; P A Bretscher
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 3.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Molecular cloning, characterization, and expression in Escherichia coli of iron superoxide dismutase cDNA from Leishmania donovani chagasi.

Authors:  S O Ismail; Y A Skeiky; A Bhatia; L A Omara-Opyene; L Gedamu
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing.

Authors:  K Denich; P Börlin; P D O'Hanley; M Howard; A W Heath
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  Thymopentin reduces the susceptibility of aged mice to cutaneous leishmaniasis by modulating CD4 T-cell subsets.

Authors:  E Cillari; S Milano; M Dieli; F Arcoleo; R Perego; F Leoni; G Gromo; A Severn; F Y Liew
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

7.  Cytokine regulation of murine leishmaniasis: interleukin 4 is not sufficient to mediate progressive disease in resistant C57BL/6 mice.

Authors:  M D Sadick; N Street; T R Mosmann; R M Locksley
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

8.  Interleukin-4 enhances interferon-gamma synthesis but inhibits development of interferon-gamma-producing cells.

Authors:  A Noble; D M Kemeny
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

9.  Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis.

Authors:  L Morris; A B Troutt; K S McLeod; A Kelso; E Handman; T Aebischer
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Cytokine production at the site of disease in human tuberculosis.

Authors:  P F Barnes; S Lu; J S Abrams; E Wang; M Yamamura; R L Modlin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.